SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3049[ keeping score ] ^BTK hit 674 a year ago. Today, it's bumped down to 351,scaram(o)uche6/11/2002
3048>> Nevertheless, an Iloperidone winner pays for all. << Yeah. But scaram(o)uche6/11/2002
3047John, QTc Ilo trial is taking too long and *street* is very nervous about. YeMiljenko Zuanic6/11/2002
3046"Do you believe that 90% of what "a Titan" tells you has any releJohn Metcalf6/10/2002
3045>> If garbage they be, they managed to fool a lot of bright people -- Dr. scaram(o)uche6/7/2002
3044If garbage they be, they managed to fool a lot of bright people -- Dr. Harry TraJMarcus6/7/2002
3043<i><b>Pfizer Stuns Biotech by Giving Up on Pagoclone</b> By Ascaram(o)uche6/7/2002
3042[ market commentary ] In the bubble, momo players ran stocks up on the back of scaram(o)uche6/4/2002
3041That's a chunk of change. Nice! Nucleic acid inactivation has been a focusscaram(o)uche6/4/2002
3040XenoPort Raises $43.9 Million to Advance its Engineered Drug Transport Technolognigel bates6/3/2002
3039old chapter, update........ Friday May 31, 8:01 am Eastern Time Press Release Sscaram(o)uche5/31/2002
3038Interesting shot today, Morgan Stanley anti-CVTX. Anybody can take a look at thscaram(o)uche5/29/2002
3037A minor milestone of interest, perhaps of no long-term significance, we'll sscaram(o)uche5/29/2002
3036Tuesday May 28, 11:08 am Eastern Time U.S. High Court Rejects Narrow Reading ofscaram(o)uche5/28/2002
3035Dow Jones headline says advisory committee endorses Amevive. Headline only. edscaram(o)uche5/23/2002
3034It's not just T. Clarke. The entire journalistic world has taken up the calscaram(o)uche5/21/2002
3033Concerning the number of times T. Clarke writes this same article, you would thiArthur Radley5/20/2002
3032Ralf: That's exactly what I've been assuming. That there is an "ascaram(o)uche5/20/2002
3031<< 1. If a company tells you that "cancer" cells are differentiaSpekulatius5/20/2002
3030How many times can the same article be written?....... <i>Monday May 20, scaram(o)uche5/20/2002
3029I usually do this rant in other threads..... cancer vaccines....... 1. If a cscaram(o)uche5/20/2002
3028<FWIW> May 20, 2002 BIOTECHNOLOGY The Stuff of Life Canada has becomSultan5/16/2002
3027VCs favor software, network infrastructure, and biotech What the Pros Are FundinJim Oravetz5/16/2002
3026this post has a life span of 3.5 hours...... quote.yahoo.com^BTK&d=c&t=scaram(o)uche5/16/2002
3025What I've always wanted to see, and am particularly interested in now? I wascaram(o)uche5/16/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News